- Home
- KNTK vs SWTX Comparison
KNTK vs SWTX Comparison
Compare KNTK & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNTK
- SWTX
- Stock Information
- Founded
- KNTK 2017
- SWTX 2017
- Country
- KNTK United States
- SWTX United States
- Employees
- KNTK N/A
- SWTX N/A
- Industry
- KNTK Natural Gas Distribution
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- KNTK Utilities
- SWTX Health Care
- Exchange
- KNTK Nasdaq
- SWTX Nasdaq
- Market Cap
- KNTK 2.7B
- SWTX 3.0B
- IPO Year
- KNTK N/A
- SWTX 2019
- Fundamental
- Price
- KNTK $49.81
- SWTX $30.78
- Analyst Decision
- KNTK Buy
- SWTX Strong Buy
- Analyst Count
- KNTK 7
- SWTX 5
- Target Price
- KNTK $43.86
- SWTX $65.80
- AVG Volume (30 Days)
- KNTK 450.1K
- SWTX 1.1M
- Earning Date
- KNTK 11-06-2024
- SWTX 10-31-2024
- Dividend Yield
- KNTK 6.03%
- SWTX N/A
- EPS Growth
- KNTK 66.54
- SWTX N/A
- EPS
- KNTK 2.58
- SWTX N/A
- Revenue
- KNTK $1,380,020,000.00
- SWTX $86,186,000.00
- Revenue This Year
- KNTK $7.69
- SWTX $3,544.39
- Revenue Next Year
- KNTK $40.87
- SWTX $95.59
- P/E Ratio
- KNTK $19.23
- SWTX N/A
- Revenue Growth
- KNTK 15.20
- SWTX N/A
- 52 Week Low
- KNTK $31.73
- SWTX $18.00
- 52 Week High
- KNTK $50.70
- SWTX $53.92
- Technical
- Relative Strength Index (RSI)
- KNTK 69.56
- SWTX 36.00
- Support Level
- KNTK $48.83
- SWTX $29.77
- Resistance Level
- KNTK $50.07
- SWTX $31.32
- Average True Range (ATR)
- KNTK 0.93
- SWTX 1.33
- MACD
- KNTK 0.16
- SWTX 0.04
- Stochastic Oscillator
- KNTK 100.00
- SWTX 24.67
About KNTK Kinetik Holdings Inc.
Kinetik is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. It operates exclusively in Texas, serving the Permian Basin and connecting fields with market hubs and other large pipelines. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines that transport molecules to the Gulf Coast enabling it to obtain exposure to export markets and international demand.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.